… efficacy of EGFR-TKIs because of their low frequency. To investigate the efficacy of gefitinib
in patients with uncommon mutations, … the NEJ002, which compared gefitinib and carboplatin-…

… EGFR mutations. When undergoing EGFR‑TKI treatment, patients with rare EGFR mutations
… between particular rare EGFR mutations and EGFR-TKIs treatment outcomes is required. …

… efficacy of gefitinib in brain metastases from NSCLC and evaluated the association of this
efficacy with EGFR mutations… association between the efficacy of gefitinib and EGFR mutations. …

… trials to evaluate the efficacy of gefitinib for tumors harboring EGFR mutation were non-…
the efficacy of gefitinib for non-adenocarcinoma NSCLC patients harboring EGFR mutations. A …

… gefitinib in patients with NSCLC according to the type of active EGFR mutation, ie exon 19
deletion or L858R point mutation… point mutation of EGFR who were on gefitinib treatment. The …

… cell lung cancer (NSCLC) to gefitinib, an EGFR tyrosine kinase inhibitor. The objective of …
efficacy of gefitinib in patients with stage III/IV NSCLC whose tumors carried EGFR mutations…

… -small cell lung cancer (NSCLC) to gefitinib, an EGFR tyrosine kinase inhibitor. The clinical
… the efficacy of gefitinib in patients with stageIII/IV NSCLC that had the EGFR mutations. …

… patients has higher EGFR mutations. Gefitinib (TKI) has shown the effectiveness in patients
… This retrospective study is to analyze the EGFR mutation rate and the efficacy of TKI on the …

… Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are … efficacy of
gefitinib and erlotinib in patients with pulmonary adenocarcinoma, whose tumor EGFR mutation …

… In the efficacy analysis according to EGFR mutation type, the T790M … Our study confirms
the previous efficacy data of afatinib for NSCLC harboring uncommon EGFR mutations other …